Home » Newsletters » BioWorld

BioWorld

Nov. 8, 2001

View Archived Issues

DeCode Files Patents On 350 Targets Discovered In-House

Other News To Note

IntraBiotics Starts Phase III Trial Of Iseganan For Oral Mucositis

Growth Factor Delivery Scaffold Restores Blood Flow To Ischemic Tissues Thus Far In Rats, Mice

Vasogen Enters Deal With Quest For Immune Modulation Therapy

Ambit Raises $10M In Series B For Drug Discovery Programs

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 17, 2024.
Second insulin receptor offers new therapeutic avenues
BioWorld Science
Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.